Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NRXS is expected to report earnings to -23 cents per share on April 14
Q4'25
Est.
$-0.24
Q3'25
Est.
$-0.24
Q2'25
Beat
by $0.03
Q4'24
Missed
by $0.27
Q1'24
Missed
by $0.22
The last earnings report on November 11 showed earnings per share of -23 cents, meeting the estimate of -23 cents. With 85.00K shares outstanding, the current market capitalization sits at 50.49M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NRXS showed earnings on November 11, 2025. You can read more about the earnings report here.